文献速递瓣膜病与结构性心脏病

逃逸X染色体失活的基因调控瓣膜肌成纤维细胞的性别差异

Genes That Escape X Chromosome Inactivation Modulate Sex Differences in Valve Myofibroblasts.
PubMed 文献 · Circulation · 2022-01-10

本研究设计水凝胶材料模拟瓣膜组织微环境,用于培养性别特异性的瓣膜间质细胞(VIC),以探究主动脉瓣狭窄性别差异的细胞内机制。结果显示雌性瓣膜叶的α-平滑肌肌动蛋白基线激活高于雄性,逃逸X染色体失活的BMX与STS基因部分通过Rho相关蛋白激酶信号调控雌性肌成纤维细胞活化增强。

要点

  • 雌性主动脉瓣叶及VIC的α-SMA基线活化高于雄性。
  • 逃逸X失活基因BMX、STS经ROCK信号部分调控雌性肌成纤维细胞活化。
  • 瓣膜病机制研究应考虑性别作为生物学变量。

核心结论

  • 体内与体外结果证实肌成纤维细胞活化通路存在性别依赖,并提示逃逸X染色体失活基因调控肌成纤维细胞活化的性别差异及主动脉瓣狭窄进展。

研究设计与样本

  • 设计水凝胶生物材料模拟瓣膜组织微环境,作为性别特异性瓣膜间质细胞(VIC)的培养平台。
  • 采用RNA测序分析驱动性别依赖活化的通路,并用小分子抑制剂和siRNA转染进行机制干预。

主要发现

  • 在健康和猪及人主动脉瓣中,雌性瓣叶的肌成纤维细胞标志物α-平滑肌肌动蛋白基线激活高于雄性瓣叶。
  • 分离培养的雌性猪和人VIC基础α-SMA应力纤维水平更高,且对水凝胶基质硬度反应进一步升高,均高于雄性VIC。
  • 雄雌猪VIC转录组分析提示Rho相关蛋白激酶信号是性别依赖肌成纤维细胞活化的潜在驱动因素。
  • 逃逸X染色体失活基因BMX和STS部分通过Rho相关蛋白激酶信号调控雌性肌成纤维细胞活化升高。
  • 用内皮细胞分泌的endothelin-1和plasminogen activator inhibitor-1处理雄雌VIC证实了上述发现。

关键数值与推荐

  • 雌性瓣叶α-SMA基线激活高于雄性瓣叶。
  • 雌性VIC基础α-SMA应力纤维水平高于雄性VIC,且对水凝胶基质硬度反应进一步升高。
  • BMX和STS(分别编码Bmx非受体酪氨酸激酶和类固醇硫酸酯酶)部分调控雌性肌成纤维细胞活化升高。

临床怎么用

  • 提示评估主动脉瓣狭窄机制与治疗时需将性别作为生物学变量考虑。
  • 逃逸X染色体失活基因及Rho相关蛋白激酶信号或为性别精准治疗的潜在靶点方向。

局限性

  • 摘要未报告具体样本量、效应量、置信区间及P值等定量数据。
  • 机制结论主要基于体外水凝胶培养与转录组分析,体内因果验证信息有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortic valve stenosis is a sexually dimorphic disease, with women often presenting with sustained fibrosis and men with more extensive calcification. However, the intracellular molecular mechanisms that drive these clinically important sex differences remain underexplored. METHODS: Hydrogel biomaterials were designed to recapitulate key aspects of the valve tissue microenvironment and to serve as a culture platform for sex-specific valvular interstitial cells (VICs; precursors to profibrotic myofibroblasts). The hydrogel culture system was used to interrogate intracellular pathways involved in sex-dependent VIC-to-myofibroblast activation and deactivation. RNA sequencing was used to define pathways involved in driving sex-dependent activation. Interventions with small molecule inhibitors and siRNA transfections were performed to provide mechanistic insight into sex-specific cellular responses to microenvironmental cues, including matrix stiffness and exogenously delivered biochemical factors. RESULTS: In both healthy porcine and human aortic valves, female leaflets had higher baseline activation of the myofibroblast marker α-smooth muscle actin compared with male leaflets. When isolated and cultured, female porcine and human VICs had higher levels of basal α-smooth muscle actin stress fibers that further increased in response to the hydrogel matrix stiffness, both of which were higher than in male VICs. A transcriptomic analysis of male and female porcine VICs revealed Rho-associated protein kinase signaling as a potential driver of this sex-dependent myofibroblast activation. Furthermore, we found that genes that escape X-chromosome inactivation such as BMX and STS (encoding for Bmx nonreceptor tyrosine kinase and steroid sulfatase, respectively) partially regulate the elevated female myofibroblast activation through Rho-associated protein kinase signaling. This finding was confirmed by treating male and female VICs with endothelin-1 and plasminogen activator inhibitor-1, factors that are secreted by endothelial cells and known to drive myofibroblast activation through Rho-associated protein kinase signaling. CONCLUSIONS: Together, in vivo and in vitro results confirm sex dependencies in myofibroblast activation pathways and implicate genes that escape X-chromosome inactivation in regulating sex differences in myofibroblast activation and subsequent aortic valve stenosis progression. Our results underscore the importance of considering sex as a biological variable to understand the molecular mechanisms of aortic valve stenosis and to help guide sex-based precision therapies.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Aguado BA, Walker CJ, Grim JC, et al. Genes That Escape X Chromosome Inactivation Modulate Sex Differences in Valve Myofibroblasts. Circulation. 2022. PMID: 35000411. doi:10.1161/CIRCULATIONAHA.121.054108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。